For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| HIV Positive Subjects | 25 eligible HIV-infected individuals for the dopaminergic arm 18F-FDOPA: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the dopaminergic (18F-FDOPA) system. 20 HIV-infected individuals for the serotonergic arm 11C-DASB: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the serotonergic (11C-DASB) system. | 0 | None | 0 | 23 | 0 | 23 | View |
| HIV Negative Subjects | 50 eligible HIV-negative individuals for the dopaminergic arm 18F-FDOPA: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the dopaminergic (18F-FDOPA) system. 20 HIV-infected individuals and 20 HIV-negative individuals for the serotonergic arm 11C-DASB: High resolution positron emission tomography (PET) of the brain and radioligands targeted against the serotonergic (11C-DASB) system. | 0 | None | 0 | 23 | 0 | 23 | View |